Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call
Fortrea (Nasdaq: FTRE) will release its fourth quarter and full year 2025 financial results before the market opens on Thursday, February 26, 2026.
Rhea-AI Summary
Fortrea (Nasdaq: FTRE) will release its fourth quarter and full year 2025 financial results before the market opens on Thursday, February 26, 2026.
The company will host a conference call at 8:00 am ET the same day with a Q&A. Participants should register on the Fortrea Investor Relations website, join at least 10 minutes early, and can access a live webcast. A replay will be posted in the events and presentations section.
Details
News Market Reaction – FTRE
On Jan 29, the day this news came out, FTRE closed 1.91% above the previous close.
Data tracked by StockTitan Argus for the Jan 29 session.
Key Figures
- Earnings release date
- February 26, 2026
- Q4 and full-year 2025 financial results release
- Conference call time
- 8:00 am ET
- Start time for Q4 and full-year 2025 earnings call
Historical Context
-
Updated J.P. Morgan Healthcare Conference presentation time and webcast details.
-
Announcement of participation and presentation at J.P. Morgan Healthcare Conference.
-
Grant of 245,000 RSUs to new hires under inducement award plan.
-
Strategic collaboration with SCTbio to align CDMO manufacturing and CRO services.
-
Participation in Citi and Evercore healthcare conferences with webcast access.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
contract research organization (CRO) medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its fourth quarter and full year 2025 financial results before the market opens on Thursday, February 26, 2026. Fortrea will host a conference call at 8:00 am ET that day to review its financial results and conduct a question-and-answer session.
To participate in the earnings call, participants should register online at the Fortrea Investor Relations website. To avoid potential delays, please join at least 10 minutes prior to the start of the call. The conference call can also be accessed through the following earnings webcast link.
A replay of the live conference call will be available shortly after the conclusion of the event and accessible on the events and presentations section of the Fortrea Investor Relations website.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team working in about 100 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com and follow us on LinkedIn and X (formerly Twitter).
Fortrea Contacts
Tracy Krumme (Investors) – 984-385-6707, tracy.krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.